If THC is weed’s troublemaker cannabinoid, then CBD is supposed to be like THC’s do-right upstanding older sibling. While THC gets you high, CBD goes around the world getting preferable legal treatment and curing sick kids.
But now it looks like CBD has stumbled onto the wrong side of the tracks.
A study released by researchers at the Virginia Commonwealth University (VCU) has found all kinds of no good stuff in samples of CBD oil. According to Leafly, the study was conducted after following up on a tip from someone who felt not too great about the stuff they found in their e-liquid from the company Diamond CBD.
To investigate, researchers looked at nine samples. Four of them contained synthetic cannabinoids and one contained the chemical DXM. Synthetic cannabinoids, often sold under the name “K2” or “Spice,” is a gnarly street drug known to cause debilitating symptoms including psychosis and temporary paralysis, and it sucks.
DXM is the active ingredient in Robitussin that gets you funked up so you can go on a brain-frying gross household chemical high called a robo trip.
When confronted with the grossness in their oil, Diamond CBD replied with a perfectly reasonable explanation. Diamond’s CEO Kevin Hagan told Consumer Reports in an interview that the samples VTC tested were the old formula, which since has seen a changeup.
He also insisted that “The company strives to provide the assurance that we supply the best, highest-quality products on the market.”
Weirdly, we can’t help but notice that Hagan doesn’t say that Diamond CBD is trying to supply high-quality products, only that it “strives to provide the assurance that it does.” In other words, it has a hard time telling people that the shit is any good.
In third-party lab results commissioned by Diamond, CBD was found to only be a “minor constituent” in their product, while the major one was melatonin, a sleep hormone. That at least sounds better than robo tripping on spice, so maybe we’re getting somewhere.
Photo via Flickr user Dave Lundy